Frazier Healthcare Partners has re-hired Kelly McCullum as an operating partner on the growth buyout team. Previously, McCullum worked at Frazier Healthcare Partners as an operating partner in 2006. He is the former president and chief operating officer at Trident.
SEATTLE–(BUSINESS WIRE)–Frazier Healthcare Partners, a leading provider of growth capital to healthcare companies, announced today that Kelly McCullum has re-joined the firm as an Operating Partner on the Growth Buyout team. He will assist the Growth Buyout team with identifying and executing investment opportunities in post-acute services space.
“We are pleased to have Kelly re-join our team,” said Brian Morfitt, General Partner. “Since our successful exit from TridentUSA Health Services, which Kelly was an integral part of building, we have remained interested in the post-acute services space. Kelly is an experienced healthcare executive who we’ve successfully backed before and has a deep network of relationships in the post-acute space that will assist in identifying, and subsequently growing, platform opportunities in the space.”
Mr. McCullum initially joined Frazier Healthcare Partners in 2006 as an Operating Partner and helped identify, source and establish TridentUSA Health Services, a national provider of laboratory and mobile radiology services. At Trident, Mr. McCullum most recently served as President and Chief Operating Officer, and oversaw all sales, operations and P&L responsibilities for the Western Division of the company. Prior to TridentUSA and Frazier, Mr. McCullum owned and operated a multi-state mobile radiology and ultrasound business servicing private homes, skilled nursing facilities, correctional facilities and other venues in the long-term care space. Prior to that, he served as Vice President and Regional General Manager of Symphony Health Services, a national service provider and IHS company.
About Frazier Healthcare Partners
Founded in 1991, Frazier Healthcare Partners is a leading provider of growth and venture capital to emerging healthcare service and biopharma companies. With nearly $2.9 billion under management, Frazier has invested in over 170 companies ranging from early-stage venture investments to buyouts of profitable lower-middle market companies. For 25 years, Frazier has established itself among entrepreneurs and seasoned executives as the preferred partner to help create and rapidly grow market leading healthcare companies. Frazier Healthcare Partners has offices in Seattle, Wash., and Menlo Park, Calif., and invests broadly across the United States, Canada and Europe.
For more information about Frazier Healthcare Partners, visit the company’s website at http://www.frazierhealthcare.com.